Immunological aspects of cancer chemotherapy

Zitvogel, Laurence, Apetoh, Lionel, Ghiringhelli, François, Kroemer, Guido·2008·Nature Reviews Immunology

DOI 10.1038/nri2216

Cited by (1,000)

Items 301–400 of 1,000

Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis
Jinfeng Chen, Ziqi Jin, Shuqing Zhang, Xiao Zhang, Peipei Li, Heng Yang, Yuting Ma · 2022 · Cellular and Molecular Immunology
Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?
James C. Sorensen, Beatrice D. Cheregi, Cara A. Timpani, Kulmira Nurgali, Alan Hayes, Emma Rybalka · 2016 · Cancer Chemotherapy and Pharmacology
A new era in anticancer peptide vaccines
Sonia A. Perez, Eric V. Hofe, Nikoletta Lea Kallinteris, Angelos D. Gritzapis, George Earl Peoples, Michael Papamichail, Constantin N. Baxevanis · 2010 · Cancer
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Jan Poleszczuk, Kimberly A. Luddy, Lu Chen, Jae K. Lee, Louis Benjamin Harrison, Brian J. Czerniecki, Hatem Hussein Soliman, Heiko Enderling · 2017 · Breast Cancer Research
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini et al. · 2021 · Biomedicines
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb, Joscelyn Bowersock, Anindya Dasgupta, G. Yancey Gillespie, Yun Yan Su, Austin Johnson, Harold Trent Spencer · 2013 · PLoS ONE
Immunocytokines: a review of molecules in clinical development for cancer therapy
Thomas List, Dario Neri · 2013 · Clinical Pharmacology Advances and Applications
Natural immunity to pluripotency antigen OCT4 in humans
Kavita M. Dhodapkar, Darren Richard Feldman, Phillip Matthews, Soroosh Radfar, Roxana Pickering, Stefan Turkula, Henry A. Zebroski, Madhav V. Dhodapkar · 2010 · Proceedings of the National Academy of Sciences
Programmed cell death 50 (and beyond)
Richard A. Lockshin · 2015 · Cell Death and Differentiation
Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6
Guoshuai Cao, Jian Wang, Xiaodong Zheng, Haiming Wei, Zhigang Tian, Rui Sun · 2015 · Journal of Biological Chemistry
Intratumoral Heterogeneity as a Therapy Resistance Mechanism
Rajasekharan Somasundaram, Jessie Villanueva, Meenhard Herlyn · 2012 · Advances in pharmacology
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
Floriana Morgillo, Marcello Dallio, Carminia Maria Della Corte, Antonietta Gerarda Gravina, Giuseppe Viscardi, C. Loguercio, Fortunato Ciardiello, Alessandro Federico · 2018 · Neoplasia
Application of Multiplex Microfluidic Electrochemical Sensors in Monitoring Hematological Tumor Biomarkers
Liang Zhu, Xiaoxue Liu, Jiao Yang, Yongcheng He, Yingchun Li · 2020 · Analytical Chemistry
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion
Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, Nadine Fournier, Lucine Christe, Yuqing Xie, Jérémy Guillot, Simge Yucel, Pumin Li, José A. Galván et al. · 2022 · Science
Combining chemotherapy with CAR-T cell therapy in treating solid tumors
Arthur Xuan Wang, Xiaojing Ong, Criselle D’Souza, Paul Joseph Neeson, Joe Jiang Zhu · 2023 · Frontiers in Immunology
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma
Pierpaolo Correale, Maria Saveria Rotundo, Cirino Botta, Maria Teresa Del Vecchio, Chiara Ginanneschi, Antonella Licchetta, Raffaele Conca, Serena Apollinari, Fabio De Luca, Pierfrancesco Tassone et al. · 2011 · Clinical Cancer Research
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
Cinzia Fionda, Alessandra Soriani, Giulia Malgarini, Maria Luisa Iannitto, Angela Santoni, Marco Cippitelli · 2009 · The Journal of Immunology
A Macromolecular Drug for Cancer Therapy via Extracellular Calcification
Ning Tang, Hanhui Li, Lihong Zhang, Xueyun Zhang, Yanni Chen, Hao Shou, Shuaishuai Feng, Xinhua Chen, Yan Luo, Ruikang Tang et al. · 2021 · Angewandte Chemie International Edition
Review on the effect of chemotherapy on the intestinal barrier: Epithelial permeability, mucus and bacterial translocation
David Dahlgren, Hans Lennernäs · 2023 · Biomedicine & Pharmacotherapy
Vaccines based on whole recombinant Saccharomyces cerevisiae cells
Andressa Ardiani, Jack P. Higgins, James W. Hodge · 2010 · FEMS Yeast Research
Immuno-enhancement effects of Yifei Tongluo Granules on cyclophosphamide-induced immunosuppression in Balb/c mice.
Yong-Jie Wang, Qiu-Chen Qi, Ang Li, Min Yang, Wei-Zhen Huang, Hong-Ya Xu, Zhong-Xi Zhao, Si-Ying Li · 2016 · Journal of Ethnopharmacology
Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
Chiara Ratti, Laura Botti, Valeria Cancila, Silvia Galvan, Ilaria Torselli, Cecilia Garofalo, Maria Cristina Manara, Lucia Bongiovanni, Cesare Fabio Valenti, Alessia Burocchi et al. · 2017 · Clinical Cancer Research
Tumour and microenvironment crosstalk in NSCLC progression and response to therapy
Zahraa Rahal, Roy El Darzi, Seyed Javad Moghaddam, Tina Cascone, Humam N. Kadara · 2025 · Nature Reviews Clinical Oncology
Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
Theodore S. Johnson, David H. Munn · 2012 · Immunological Investigations
Immunogenicity and immunomodulatory properties of HPMA-based polymers☆
Blanka Řı́hová, Marek Kovář · 2009 · Advanced Drug Delivery Reviews
Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
Mengying He, Tao Yang, Yuhan Wang, Mengyuan Wang, Xingye Chen, Dawei Ding, Yiran Zheng, Huabing Chen · 2021 · Advanced Healthcare Materials
DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
Jennifer L. Guerriero, Dara Ditsworth, Joseph M. Catanzaro, Gregory J. Sabino, Martha B. Furie, Richard R. Kew, Howard C. Crawford, Wei‐Xing Zong · 2011 · The Journal of Immunology
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Giovanna Lollo, Marie Vincent, Gabriela Ullio-Gamboa, Laurent P. Lemaire, Florence Franconi, Dominique Couez, Jean‐Pierre Benoît · 2015 · International Journal of Pharmaceutics
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
Alice Hervieu, Cédric Rébé, Frédérique Végran, Fanny Chalmin, Mélanie Bruchard, Pierre Vabres, Lionel Apétoh, François Ghiringhelli, Grégoire Mignot · 2012 · Journal of Investigative Dermatology
Tumor stress, cell death and the ensuing immune response
Evelyn Ullrich, Mathieu Bonmort, Grégoire Mignot, Guido Kroemer, Laurence Zitvogel · 2007 · Cell Death and Differentiation
Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Dalil Hannani, Antonella Sistigu, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel · 2011 · The Cancer Journal
Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis
Yu Jin Lim, Jaemoon Koh, Sehui Kim, Sang Rok Jeon, Eui Kyu Chie, Kyubo Kim, Gyeong Hoon Kang, Sae‐Won Han, Tae‐You Kim, Seung‐Yong Jeong et al. · 2017 · International Journal of Radiation Oncology*Biology*Physics
Tumor‐infiltrating dendritic cells exhibit defective cross‐presentation of tumor antigens, but is reversed by chemotherapy
Alison M. McDonnell, Willem Joost Lesterhuis, Andrea Khong, Anna K. Nowak, Richard Lake, Andrew J Currie, Bruce W. S. Robinson · 2014 · European Journal of Immunology
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
Lévesque, Sarah, Le Naour, Julie, Pietrocola, Federico, Paillet, Juliette, Kremer, Margerie, Castoldi, Francesca, Baracco, Elisa E., Wang, Yan, Vacchelli, Erika, Stoll, Gautier et al. · 2019 · OncoImmunology
Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models
Maria Jure‐Kunkel, Gregg R. Masters, Emel Girit, Gennaro Dito, Francis Y. Lee, John T. Hunt, Rachel W. Humphrey · 2013 · Cancer Immunology Immunotherapy
Immune-priming of the Tumor Microenvironment by Radiotherapy
Vafa Shahabi, Michael A. Postow, David P. Tuck, Jedd D. Wolchok · 2013 · American Journal of Clinical Oncology
NK cell-based therapeutics for lung cancer
Alan Graham Pockley, Peter W. Vaupel, Gabriele Multhoff · 2019 · Expert Opinion on Biological Therapy
Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy
Zhi‐Chun Ding, Lei Huang, Bruce R. Blazar, Hideo Yagita∥, Andrew L. Mellor, David H. Munn, Gang Zhou · 2012 · Blood
Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study
Camille Laurent, Sabina Müller, Catherine Do, Talal Al Saati, Sophie Allart, Luigi Maria Larocca, Stefan Hohaus, Sophie Duchez, Anne Quillet‐Mary, Guy Laurent et al. · 2011 · Blood
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
Martin Pölcher, Michael Braun, Nicolaus Friedrichs, Christian Rudlowski, Eva Bercht, Rolf Fimmers, Axel Sauerwald, Mignon-Denise Keyver-Paik, Kirsten Kübler, Reinhard Büttner et al. · 2010 · Cancer Immunology Immunotherapy
Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
Marieke F. Fransen, Ramon Arens, Cornelis J.M. Melief · 2012 · International Journal of Cancer
The Janus face of dendritic cells in cancer
Nathalie Chaput, Rosa Conforti, Sophie Viaud, Alan Spatz, Laurence Zitvogel · 2008 · Oncogene
Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation
Benjamin Joachim Schmiedel, Viktor Arélin, Frank Grünebach, Matthias Krusch, Susanne M. Schmidt, Helmut Rainer Salih · 2010 · International Journal of Cancer
Learning from Host-Defense Peptides: Cationic, Amphipathic Peptoids with Potent Anticancer Activity
Wei Huang, Jiwon Seo, Stephen B. Willingham, Ann M. Czyzewski, Mark L. Gonzalgo, Irving L. Weissman, Annelise E. Barron · 2014 · PLoS ONE
Harnessing the immune response to treat cancer
Henry John Steer, Richard Lake, Anna K. Nowak, Bruce W.S. Robinson · 2010 · Oncogene
Gemcitabine depletes regulatory T‐cells in human and mice and enhances triggering of vaccine‐specific cytotoxic T‐cells
Rettig, Lorna, Seidenberg, Samuel, Parvanova, Iana, Samaras, Panagiotis, Knuth, Alexander, Pascolo, Steve · 2011 · International Journal of Cancer
Desirable cell death during anticancer chemotherapy
Clara Locher, Rosa Conforti, Laetitia Aymeric, Yuting Ma, Takahiro Yamazaki, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apétoh, Yannis Morel et al. · 2010 · Annals of the New York Academy of Sciences
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
Oliver J. Stoetzer, Debora M.I. Fersching, Christoph Salat, Oliver Steinkohl, Christian J. Gabka, Ulrich Hamann, Michael Braun, Axel Mario Feller, Volker Heinemann, Barbara Siegele et al. · 2012 · Tumor Biology
Cancer vaccines: on the threshold of success
Leisha A. Emens · 2008 · Expert Opinion on Emerging Drugs
Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, P Stieber, Stefan Holdenrieder · 2012 · Tumor Biology
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Xin Liu, R. Newton, Steven Friedman, Peggy Scherle · 2009 · Current Cancer Drug Targets
Trained immunity: induction of an inflammatory memory in disease
Titus Schlüter, Yuri van Elsas, Bram Priem, Athanasios Ziogas, Mihai Gheorghe Netea · 2025 · Cell Research
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant, Catalina Suarez‐Cuervo, G. Yancey Gillespie, James M. Markert, Burt Nabors, Sreelatha Meleth, Richard D. Lopez, Lawrence S. Lamb · 2009 · Neuro-Oncology
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
Xia Wu, Qinmei Feng, Ying Wang, Jun Shi, Hailiang Ge, Wen J. Di · 2009 · Cancer Immunology Immunotherapy
Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
Genevieve M. Weir, Robert Liwski, Marc Mansour · 2011 · Cancers
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers
Maria Davern, Joanne Lysaght · 2020 · Cancer Letters
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
Vera M. Kho, Vera E. Mekers, Paul N. Span, Johan Bussink, Gosse J. Adema · 2021 · Cellular Immunology
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
Chandan Verma, Viriya Kaewkangsadan, Jennifer M. Eremin, Gerard Cowley, Mohammad Ilyas, Mohamed El‐Sheemy, Oleg Eremin · 2015 · Journal of Translational Medicine
Wogonin Induced Calreticulin/Annexin A1 Exposure Dictates the Immunogenicity of Cancer Cells in a PERK/AKT Dependent Manner
Yong Yang, Xian-Jing Li, Zhen Chen, Xuan-Xuan Zhu, Jing Wang, Linbo Zhang, Lei Qiang, Yanjun Ma, Zhiyu Li, Qinglong Guo et al. · 2012 · PLoS ONE
Immunomodulatory Activity and Partial Characterisation of Polysaccharides from Momordica charantia
Yuanyuan Deng, Yang Yi, Lifang Zhang, Ruifen Zhang, Yan Zhang, Zhencheng Wei, Xiao-Jun Tang, Mingwei Zhang · 2014 · Molecules
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
Mandy van Gulijk, Floris F. Dammeijer, Joachim G.J.V. Aerts, Heleen H. Vroman · 2018 · Frontiers in Immunology
Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy
Xiang Li, Qinghao Zhou, Abd Al-Wali Mohammed M. Japir, Debabrata Dutta, Nannan Lu, Zhishen Ge · 2022 · ACS Nano
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
Alfred Zippelius, Sara M. Tolaney, Paolo Tarantino, Joseph P. Balthasar, Greg M. Thurber · 2025 · Nature reviews. Cancer
Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
Xiaosong Wu, Tao Yi, Jun Hou, Xiuqin Meng, Jumei Shi · 2012 · Neoplasia
Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide
Federica Moschella, Mara Valentini, Eleonora Aricò, Iole Macchia, Paola Sestili, Maria Teresa D’Urso, Cristiano Alessandri, Filippo Belardelli, Enrico Proietti · 2011 · Cancer Research
Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
Anne-Sophie Chrétien, Aude Le Roy, Norbert Vey, Thomas Prébet, Didier Blaise, Cyril Fauriat, Daniel Olive · 2014 · Frontiers in Immunology
Targeting the interleukin-1 pathway in patients with hematological disorders
Charlotte E. M. de Mooij, Mihai Gheorghe Netea, Walter J. F. M. van der Velden, Nicole M. A. Blijlevens · 2017 · Blood
Oligo Hyaluronan‐Coated Silica/Hydroxyapatite Degradable Nanoparticles for Targeted Cancer Treatment
Yao Kang, Wen Ce Sun, Shuyi Li, Mingle Li, Jiangli Fan, Jianjun Du, Xing‐Jie Liang, Xiaojun Peng · 2019 · Advanced Science
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
E. Tanis, Catherine Julié, Jean‐François Emile, Murielle E.L. Mauer, Bernard Nordlinger, Daniela Ellen Aust, Arnaud D. Roth, Manfred Paul Lutz, Thomas Gruenberger, Fritz Wrba et al. · 2015 · European Journal of Cancer
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
Antonio Gnoni, Nicola Silvestris, Antonella Licchetta, Daniele Santini, Mario Scartozzi, Roberto Ria, Salvatore Pisconti, Fausto Petrelli, Angelo Vacca, Vito Lorusso · 2015 · Critical Reviews in Oncology/Hematology
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
Zin War Myint, Gaurav Goel · 2017 · Journal of Hematology & Oncology
A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases
Mi Jian, Li Ren, Guodong He, Qi Lin, Wentao Tang, Yijiao Chen, Jingwen Chen, Tianyu Liu, Meiling Ji, Ye Wei et al. · 2020 · Journal of Translational Medicine
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
Mu Qi, Masoud Najafi · 2021 · International Immunopharmacology
T-cell repertoire diversity: friend or foe for protective antitumor response?
Nicla Porciello, Ornella Franzese, Lorenzo D’Ambrosio, Belinda Palermo, Paola Nisticò · 2022 · Journal of Experimental & Clinical Cancer Research
Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy
Elena Muraro, Elisa Comaro, Renato Talamini, Elisa Turchet, Gianmaria Miolo, Simona Scalone, Loredana Militello, Davide Lombardi, Simon Spazzapan, Tiziana Perin et al. · 2015 · Journal of Translational Medicine
T cell‐mediated immunoregulation in the gastrointestinal tract
Leslie Saurer, Christoph Mueller · 2009 · Allergy
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses
Sofia R. Gameiro, Jorge A. Caballero, Jack P. Higgins, David Apelian, James W. Hodge · 2011 · Cancer Immunology Immunotherapy
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
Clarissa Anni Wild, Sven Brandau, Ramin Lotfi, Stefan Mattheis, Xiang Gu, Stephan Lang, Christoph Bergmann · 2012 · Oral Oncology
Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses
Amir Dashti, Marzieh Ebrahimi, Jamshid Hadjati, Arash Memarnejadian, Seyed Mohammad Moazzeni · 2016 · Cancer Letters
Cancer therapy and vaccination
Hamdy A.A. Aly · 2012 · Journal of Immunological Methods
Emerging Immunotherapies in the Treatment of Non–small Cell Lung Cancer (NSCLC)
Corey Jay Langer · 2014 · American Journal of Clinical Oncology
Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles
Shira Engelberg, Julia Modrejewski, Johanna‐Gabriela Walter, Yoav D. Livney, Yehuda G. Assaraf · 2018 · Oncotarget
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, Xiangsheng Liu · 2022 · ACS Nano
Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer
Angelova, Assia L., Grekova, Svitlana P., Heller, Anette, Kuhlmann, Olga, Soyka, Esther, Giese, Thomas, Aprahamian, Marc, Bour, Gaétan, Rüffer, Sven, Cziepluch, Celina et al. · 2014 · Journal of Virology
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
Luca Antonioli, Sergey V. Novitskiy, Kris F. Sachsenmeier, Matteo Fornai, Corrado Blandizzi, György Haskó · 2017 · Drug Discovery Today
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
Valentina Sustr, Philipp Foessleitner, Herbert Kiss, Alex Farr · 2020 · Journal of Fungi
Unresolved inflammation: ‘immune tsunami’ or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancer
Mahin Khatami · 2011 · Expert Opinion on Biological Therapy
Impassion132 Phase Iii Trial: Atezolizumab And Chemotherapy In Early Relapsing Metastatic Triple-Negative Breast Cancer
Javier Cortés, Fabrice André, Anthony Gonçalvès, Sherko Kümmel, Miguel Mart´n, Peter Schmid, Florian Schütz, Sandra M. Swain, Valerie Easton, Erika K. Pollex et al. · 2019 · Future Oncology
Immunogenic nanomedicine based on GSH-responsive nanoscale covalent organic polymers for chemo-sonodynamic therapy
Fengyun Shen, Danlei Tao, Rui Peng, Yao He, Zhuang Liu, Jiansong Ji, Liangzhu Feng · 2022 · Biomaterials
Immunogenic Cell Death in Cancer Therapy
Olga S. Troitskaya, Diana D. Novak, Vladimir Alexandrovich Richter, Olga A. Koval · 2022 · Acta Naturae
Differential effects of Paclitaxel on dendritic cell function
Justin John, Mohamed Ismail, Catherine L. Riley, Jonathan M. Askham, Richard Morgan, Alan A. Melcher, Hardev Pandha · 2010 · BMC Immunology
CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma
Karin U. Sørenmo, Erika Krick, Christina Marie Coughlin, Beth Overley, Thomas P. Gregor, Robert H. Vonderheide, Nicola J. Mason · 2011 · PLoS ONE
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier
Jingjing Sun, Yichao Chen, Yixian Huang, Wenchen Zhao, Yanhua Liu, Raman Venkataramanan, Binfeng Lu, Song Li · 2017 · Acta Pharmacologica Sinica
The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
Michal Kuczma, Zhi‐Chun Ding, Tao Li, Tsadik Ghebreamlak Habtetsion, Tingting Chen, Zhonglin Hao, Locke Johnson Bryan, Nagendra Singh, James N. Kochenderfer, Gang Zhou · 2017 · Oncotarget
Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients
Yvonne Nadine Fahmueller, Dorothea Nagel, RT Hoffmann, Klaus Tatsch, Tobias Franz Jakobs, P Stieber, Stefan Holdenrieder · 2012 · International Journal of Cancer
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
Chiara Napoletano, Filippo Bellati, Rachele Landi, Simona Pauselli, Cláudia Marchetti, Valeria V. Visconti, Patrizio Sale, Marco Liberati, Aurelia Rughetti, Luigi Frati et al. · 2009 · Journal of Cellular and Molecular Medicine
‘Yin and Yang’ in inflammation: duality in innate immune cell function and tumorigenesis
M. Khatami · 2008 · Expert Opinion on Biological Therapy
Autophagy in natural and therapy-driven anticancer immunosurveillance
Federico Pietrocola, José Manuel Bravo‐San Pedro, Lorenzo Galluzzi, Guido Kroemer · 2017 · Autophagy
Immunotherapy in breast cancer
Soley Bayraktar, Sameer Ahmad Batoo, Scott H. Okuno, Stefan Glück · 2019 · Journal of Carcinogenesis
ABC triblock bottlebrush copolymer-based injectable hydrogels: design, synthesis, and application to expanding the therapeutic index of cancer immunochemotherapy
Farrukh Vohidov, Lauren E. Milling, Qixian Chen, Wenxu Zhang, Sachin H. Bhagchandani, Hung V.‐T. Nguyen, Darrell J. Irvine, Jeremiah A. Johnson · 2020 · Chemical Science